These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 37807060)
1. Knockdown of NR3C1 inhibits the proliferation and migration of clear cell renal cell carcinoma through activating endoplasmic reticulum stress-mitophagy. Yan M; Wang J; Wang H; Zhou J; Qi H; Naji Y; Zhao L; Tang Y; Dai Y J Transl Med; 2023 Oct; 21(1):701. PubMed ID: 37807060 [TBL] [Abstract][Full Text] [Related]
2. LncRNA LBX2-AS1 promotes proliferation and migratory capacity of clear cell renal cell carcinoma through mitophagy. Wang B; Wei Y; Han T; Ji P; Miao H; Wu X; Qian J; Shao P Eur J Med Res; 2024 Feb; 29(1):103. PubMed ID: 38326905 [TBL] [Abstract][Full Text] [Related]
3. MSRB3 promotes the progression of clear cell renal cell carcinoma via regulating endoplasmic reticulum stress. Ye X; Liang T; Deng C; Li Z; Yan D Pathol Res Pract; 2020 Feb; 216(2):152780. PubMed ID: 31889586 [TBL] [Abstract][Full Text] [Related]
4. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation. Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887 [TBL] [Abstract][Full Text] [Related]
5. Mitophagy and clear cell renal cell carcinoma: insights from single-cell and spatial transcriptomics analysis. Jiang L; Ren X; Yang J; Chen H; Zhang S; Zhou X; Huang J; Jiang C; Gu Y; Tang J; Yang G; Chi H; Qin J Front Immunol; 2024; 15():1400431. PubMed ID: 38994370 [TBL] [Abstract][Full Text] [Related]
6. Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma. Xiang J; Liu W; Liu S; Wang T; Tang H; Yang J J Cancer Res Clin Oncol; 2023 Nov; 149(17):16015-16030. PubMed ID: 37689589 [TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation. Gui D; Dong Z; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y Cancer Med; 2021 Jun; 10(11):3674-3688. PubMed ID: 33973730 [TBL] [Abstract][Full Text] [Related]
8. HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma. Qiu B; Ackerman D; Sanchez DJ; Li B; Ochocki JD; Grazioli A; Bobrovnikova-Marjon E; Diehl JA; Keith B; Simon MC Cancer Discov; 2015 Jun; 5(6):652-67. PubMed ID: 25829424 [TBL] [Abstract][Full Text] [Related]
9. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway. Xu J; Wang Y; Jiang J; Yin C; Shi B J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma. Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019 [TBL] [Abstract][Full Text] [Related]
11. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T. Wu Y; Zhang C; Peng D; He S; Huang C; Qian J; Zhu W; Feng N; Gong Y; Li X; Zhou L Hum Cell; 2022 Mar; 35(2):542-556. PubMed ID: 35129808 [TBL] [Abstract][Full Text] [Related]
12. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis. Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014 [TBL] [Abstract][Full Text] [Related]
13. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway. Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway. Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471 [TBL] [Abstract][Full Text] [Related]
15. miR-155-5p Promotes Cell Proliferation and Migration of Clear Cell Renal Cell Carcinoma by Targeting PEG3. Wu H; Wu H; Sun P; Zhu D; Ma M; Fan W Urol Int; 2021; 105(9-10):906-915. PubMed ID: 34192708 [TBL] [Abstract][Full Text] [Related]
16. YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis. Cao JJ; Zhao XM; Wang DL; Chen KH; Sheng X; Li WB; Li MC; Liu WJ; He J Oncol Rep; 2014 Oct; 32(4):1594-600. PubMed ID: 25175178 [TBL] [Abstract][Full Text] [Related]
17. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro. Xu Y; Wu G; Zhang J; Li J; Ruan N; Zhang J; Zhang Z; Chen Y; Zhang Q; Xia Q Biomed Res Int; 2020; 2020():8409239. PubMed ID: 32908919 [TBL] [Abstract][Full Text] [Related]
18. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15. Deng JH; Zheng GY; Li HZ; Ji ZG Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538 [TBL] [Abstract][Full Text] [Related]
19. Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma. Zhao L; Wang Z; Xu Y; Zhang P; Qiu J; Nie D; Wu G; Chen C; Chang Y; Xia Q Pathol Res Pract; 2023 Aug; 248():154641. PubMed ID: 37467634 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]